449 related articles for article (PubMed ID: 17851730)
1. Characterization of R peptide of murine leukemia virus envelope glycoproteins in syncytium formation and entry.
Kubo Y; Tominaga C; Yoshii H; Kamiyama H; Mitani C; Amanuma H; Yamamoto N
Arch Virol; 2007; 152(12):2169-82. PubMed ID: 17851730
[TBL] [Abstract][Full Text] [Related]
2. Genistein, a protein tyrosine kinase inhibitor, suppresses the fusogenicity of Moloney murine leukemia virus envelope protein in XC cells.
Kubo Y; Ishimoto A; Amanuma H
Arch Virol; 2003 Oct; 148(10):1899-914. PubMed ID: 14551814
[TBL] [Abstract][Full Text] [Related]
3. Mutational analysis of the R peptide cleavage site of Moloney murine leukaemia virus envelope protein.
Kubo Y; Amanuma H
J Gen Virol; 2003 Aug; 84(Pt 8):2253-2257. PubMed ID: 12867658
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of infectious murine leukemia virus production by Fv-4 env gene products exerting dominant negative effect on viral envelope glycoprotein.
Takeda A; Matano T
Microbes Infect; 2007; 9(14-15):1590-6. PubMed ID: 18023391
[TBL] [Abstract][Full Text] [Related]
5. TR1.3 viral pathogenesis and syncytium formation are linked to Env-Gag cooperation.
Murphy SL; Gaulton GN
J Virol; 2007 Oct; 81(19):10777-85. PubMed ID: 17634219
[TBL] [Abstract][Full Text] [Related]
6. An essential role for the His-8 residue of the SDF-1alpha-chimeric, tropism-redirected Env protein of the Moloney murine leukemia virus in regulating postbinding fusion events.
Katane M; Fujita R; Takao E; Kubo Y; Aoki Y; Amanuma H
J Gene Med; 2004 Mar; 6(3):260-7. PubMed ID: 15026987
[TBL] [Abstract][Full Text] [Related]
7. A proline-rich motif downstream of the receptor binding domain modulates conformation and fusogenicity of murine retroviral envelopes.
Lavillette D; Maurice M; Roche C; Russell SJ; Sitbon M; Cosset FL
J Virol; 1998 Dec; 72(12):9955-65. PubMed ID: 9811733
[TBL] [Abstract][Full Text] [Related]
8. Analysis of mutations within the cytoplasmic domain of the Moloney murine leukemia virus transmembrane protein.
Thomas A; Gray KD; Roth MJ
Virology; 1997 Jan; 227(2):305-13. PubMed ID: 9018129
[TBL] [Abstract][Full Text] [Related]
9. Cytoplasmic R-peptide of murine leukemia virus envelope protein negatively regulates its interaction with the cell surface receptor.
Kubo Y; Izumida M; Togawa K; Zhang F; Hayashi H
Virology; 2019 Jun; 532():82-87. PubMed ID: 31035110
[TBL] [Abstract][Full Text] [Related]
10. Masking of retroviral envelope functions by oligomerizing polypeptide adaptors.
Morling FJ; Peng KW; Cosset FL; Russell SJ
Virology; 1997 Jul; 234(1):51-61. PubMed ID: 9234946
[TBL] [Abstract][Full Text] [Related]
11. Role of a third extracellular domain of an ecotropic receptor in Moloney murine leukemia virus infection.
Bae EH; Park SH; Jung YT
J Microbiol; 2006 Aug; 44(4):447-52. PubMed ID: 16953181
[TBL] [Abstract][Full Text] [Related]
12. Use of different but overlapping determinants in a retrovirus receptor accounts for non-reciprocal interference between xenotropic and polytropic murine leukemia viruses.
Van Hoeven NS; Miller AD
Retrovirology; 2005 Dec; 2():76. PubMed ID: 16354307
[TBL] [Abstract][Full Text] [Related]
13. Lentiviral vectors pseudotyped with envelope glycoproteins derived from gibbon ape leukemia virus and murine leukemia virus 10A1.
Stitz J; Buchholz CJ; Engelstädter M; Uckert W; Bloemer U; Schmitt I; Cichutek K
Virology; 2000 Jul; 273(1):16-20. PubMed ID: 10891403
[TBL] [Abstract][Full Text] [Related]
14. Mutations in the cytoplasmic tail of murine leukemia virus envelope protein suppress fusion inhibition by R peptide.
Li M; Yang C; Compans RW
J Virol; 2001 Mar; 75(5):2337-44. PubMed ID: 11160737
[TBL] [Abstract][Full Text] [Related]
15. Construction of replication-competent oncolytic retroviral vectors expressing R peptide-truncated 10A1 envelope glycoprotein.
Lee ES; Jin SY; Kang BK; Jung YT
J Virol Methods; 2019 Jun; 268():32-36. PubMed ID: 30898575
[TBL] [Abstract][Full Text] [Related]
16. MLV-derived retroviral vectors selective for CD4-expressing cells and resistant to neutralization by sera from HIV-infected patients.
Stitz J; Steidl S; Merget-Millitzer H; König R; Müller P; Nocken F; Engelstädter M; Bobkova M; Schmitt I; Kurth R; Buchholz CJ; Cichutek K
Virology; 2000 Feb; 267(2):229-36. PubMed ID: 10662618
[TBL] [Abstract][Full Text] [Related]
17. Changes in a murine leukemia virus (MLV) receptor encoded by an alphavirus vector during passage in cells expressing the MLV envelope.
Kazachkov Y; Long D; Wang C; Silver J
Virology; 2000 Feb; 267(1):124-32. PubMed ID: 10648189
[TBL] [Abstract][Full Text] [Related]
18. Two point mutations increase targeted transduction and stabilize vector association of a modified retroviral envelope protein.
Zavorotinskaya T; Albritton LM
Mol Ther; 2001 Mar; 3(3):323-8. PubMed ID: 11273774
[TBL] [Abstract][Full Text] [Related]
19. O-sulfate groups of heparin are critical for inhibition of ecotropic murine leukemia virus infection by heparin.
Seki Y; Mizukura M; Ichimiya T; Suda Y; Nishihara S; Masuda M; Takase-Yoden S
Virology; 2012 Mar; 424(1):56-66. PubMed ID: 22226323
[TBL] [Abstract][Full Text] [Related]
20. Intracellular trafficking of Gag and Env proteins and their interactions modulate pseudotyping of retroviruses.
Sandrin V; Muriaux D; Darlix JL; Cosset FL
J Virol; 2004 Jul; 78(13):7153-64. PubMed ID: 15194792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
